Literature DB >> 16365274

Intralesional immunotherapy for genital warts.

Mark King, Sandra Marchese Johnson, Thomas D Horn.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16365274     DOI： 10.1001/archderm.141.12.1606

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  6 in total

1.  Intralesional Immunotherapy with Measles Mumps Rubella Vaccine for the Treatment of Anogenital Warts: An Open-label Study.

Authors:  Shilpi Sharma; Saurabh Agarwal
Journal:  J Clin Aesthet Dermatol       Date:  2020-08-01

Review 2.  Immunomodulators in warts: Unexplored or ineffective?

Authors:  Surabhi Sinha; Vineet Relhan; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

3.  Comparative Study of Efficacy of Intralesional Purified Protein Derivative (PPD) Versus Intralesional Measles, Mumps, and Rubella (MMR) Vaccine in Management of Multiple Viral Warts.

Authors:  Krishna B Bhalala; Shital Poojary; Kapisha Sunny Shah
Journal:  J Cutan Aesthet Surg       Date:  2021 Oct-Dec

4.  Triple Intralesional Antigen Immunotherapy versus Monoantigen in the Treatment of Multiple Recalcitrant Warts.

Authors:  Ahmad A Nofal; Basma M Elkholy; Esraa R Abd-Elmonsef; Hagar O Nofal
Journal:  Dermatol Ther (Heidelb)       Date:  2022-04-21

Review 5.  Intralesional Measles-Mumps-Rubella Vaccine for Genital Warts: Report of two cases with a review of literature.

Authors:  Al-Mu'tasim Al-Qassabi; Fahad Al-Farsi
Journal:  Sultan Qaboos Univ Med J       Date:  2022-08-25

6.  Immunotherapy with intralesional Candida albicans antigen in resistant or recurrent warts: a study.

Authors:  Imran Majid; Saher Imran
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.